Full-length dominant-negative survivin for cancer immunotherapy. (Q40604222)
Jump to navigation
Jump to search
scientific article published on December 2003
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Full-length dominant-negative survivin for cancer immunotherapy. |
scientific article published on December 2003 |
Statements
Full-length dominant-negative survivin for cancer immunotherapy (English)
Vladimir Pisarev
Bin Yu
Raoul Salup
Simon Sherman
Dmitry I Gabrilovich
1 December 2003